Lexaria Bioscience (LEXX) Shares Outstanding (Diluted Average) (2010 - 2026)

Lexaria Bioscience has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $22.9 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $22.9 million, up 30.78% year-over-year; the trailing twelve-month figure through Feb 2026 was $22.9 million (up 30.78% YoY), and the FY2025 annual result was $18.0 million, up 45.34% from the prior year.
• Shares Outstanding (Diluted Average) came in at $22.9 million for Q1 2026 at Lexaria Bioscience, up from $21.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $22.9 million in Q1 2026 to a low of $6.6 million in Q3 2023.
• The 4-year median for Shares Outstanding (Diluted Average) is $16.7 million (2024), against an average of $15.0 million.
• Across the five-year window, Shares Outstanding (Diluted Average) soared 87.24% in 2024 and increased 28.24% in 2025, its largest moves.
• Lexaria Bioscience's Shares Outstanding (Diluted Average) stood at $9.1 million in 2023, then jumped by 84.15% to $16.7 million in 2024, then climbed by 28.24% to $21.4 million in 2025, then grew by 7.14% to $22.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $22.9 million (Q1 2026), $21.4 million (Q4 2025), and $18.0 million (Q3 2025), per Business Quant data.